Xu N - Search Results

1

Prognostic significance of vascular endothelial growth factor immunohistochemical expression in gastric cancer: a meta-analysis.

Peng L, Zhan P, Zhou Y, Fang W, Zhao P, Zheng Y, Xu N. Peng L, et al. Among authors: xu n. Mol Biol Rep. 2012 Oct;39(10):9473-84. doi: 10.1007/s11033-012-1812-8. Epub 2012 Jun 23. Mol Biol Rep. 2012. PMID: 22729879

2

A Phase II trial of oxaliplatin, folinic acid, and 5-fluorouracil (FOLFOX4) as first-line chemotherapy in advanced colorectal cancer: a China single-center experience.

Xu N, Fang WJ, Zhang XC, Yu LF, Bao HY, Shi GM, Huang S, Shen P. Xu N, et al. Cancer Invest. 2007;25(7):599-605. doi: 10.1080/07357900701470739. Cancer Invest. 2007. PMID: 17882631 Clinical Trial.

3

Primary primitive neuroectodermal tumor of the urinary bladder: a case report and literature review.

Zheng Y, Tan F, Wang L, Xu N, Mou H. Zheng Y, et al. Among authors: xu n. Med Oncol. 2011 Dec;28 Suppl 1:S388-91. doi: 10.1007/s12032-010-9680-3. Epub 2010 Sep 18. Med Oncol. 2011. PMID: 20852971 Review.

4

Celastrol induces apoptosis in non-small-cell lung cancer A549 cells through activation of mitochondria- and Fas/FasL-mediated pathways.

Mou H, Zheng Y, Zhao P, Bao H, Fang W, Xu N. Mou H, et al. Among authors: xu n. Toxicol In Vitro. 2011 Aug;25(5):1027-32. doi: 10.1016/j.tiv.2011.03.023. Epub 2011 Apr 3. Toxicol In Vitro. 2011. PMID: 21466843

5

RRM1 and ERCC1 expression in peripheral blood versus tumor tissue in gemcitabine/carboplatin-treated advanced non-small cell lung cancer.

Zhang GB, Chen J, Wang LR, Li J, Li MW, Xu N, Wang Y, Shentu JZ. Zhang GB, et al. Among authors: xu n. Cancer Chemother Pharmacol. 2012 May;69(5):1277-87. doi: 10.1007/s00280-012-1834-x. Cancer Chemother Pharmacol. 2012. PMID: 22302408 Clinical Trial.

6

Characteristic CYP2A6 genetic polymorphisms detected by TA cloning-based sequencing in Chinese digestive system cancer patients with S-1 based chemotherapy.

Fang WJ, Mou HB, Jin DZ, Zheng YL, Zhao P, Mao CY, Peng L, Huang MZ, Xu N. Fang WJ, et al. Among authors: xu n. Oncol Rep. 2012 May;27(5):1606-10. doi: 10.3892/or.2012.1678. Epub 2012 Feb 7. Oncol Rep. 2012. PMID: 22322240

7

Retroperitoneal primary mucinous adenocarcinoma: A case report.

Jiang H, Jin K, You Q, Fang W, Xu N. Jiang H, et al. Among authors: xu n. Oncol Lett. 2011 Jul;2(4):633-636. doi: 10.3892/ol.2011.319. Epub 2011 May 16. Oncol Lett. 2011. PMID: 22848240 Free PMC article.

8

New EGFR-TKI: a case report of recurrent lung adenocarcinoma successfully treated with icotinib.

Zheng Y, Fang W, Liu X, Xu N. Zheng Y, et al. Among authors: xu n. Tumori. 2012 Jul-Aug;98(4):e102-4. doi: 10.1177/030089161209800422. Tumori. 2012. PMID: 23052173

9

Hand-foot syndrome in a patient with metastatic lung adenocarcinoma induced by high-dose icotinib: A case report and review of the literature.

Zheng Y, Fang W, Xu N. Zheng Y, et al. Among authors: xu n. Oncol Lett. 2012 Dec;4(6):1341-1343. doi: 10.3892/ol.2012.904. Epub 2012 Sep 10. Oncol Lett. 2012. PMID: 23205134 Free PMC article.

10

Complete remission of platinum-refractory primary Fallopian tube carcinoma with third-line gemcitabine plus cisplatin: A case report and review of the literature.

Xu Q, Xu N, Fang W, Zhao P, Mao C, Zheng Y, Mou H. Xu Q, et al. Among authors: xu n. Oncol Lett. 2013 May;5(5):1601-1604. doi: 10.3892/ol.2013.1232. Epub 2013 Mar 6. Oncol Lett. 2013. PMID: 23759738 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,037 results

Search Page

Filters